Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/55011, first published .
Socioeconomic Disparities in Six Common Cancer Survival Rates in South Korea: Population-Wide Retrospective Cohort Study

Socioeconomic Disparities in Six Common Cancer Survival Rates in South Korea: Population-Wide Retrospective Cohort Study

Socioeconomic Disparities in Six Common Cancer Survival Rates in South Korea: Population-Wide Retrospective Cohort Study

1National Cancer Control Institute, National Cancer Center, , Goyang, , Republic of Korea

2Department of Public Health, Graduate School, Yonsei University, , Seoul, , Republic of Korea

3Graduate School of Cancer Science and Policy, National Cancer Center, , Goyang, , Republic of Korea

Corresponding Author:

Mina Suh, MD, PhD


Background: In South Korea, the cancer incidence rate has increased by 56.5% from 2001 to 2021. Nevertheless, the 5-year cancer survival rate from 2017 to 2021 increased by 17.9% compared with that from 2001 to 2005. Cancer survival rates tend to decline with lower socioeconomic status, and variations exist in the survival rates among different cancer types. Analyzing socioeconomic patterns in the survival of patients with cancer can help identify high-risk groups and ensure that they benefit from interventions.

Objective: The aim of this study was to analyze differences in survival rates among patients diagnosed with six types of cancer—stomach, colorectal, liver, breast, cervical, and lung cancers—based on socioeconomic status using Korean nationwide data.

Methods: This study used the Korea Central Cancer Registry database linked to the National Health Information Database to follow up with patients diagnosed with cancer between 2014 and 2018 until December 31, 2021. Kaplan-Meier curves stratified by income status were generated, and log-rank tests were conducted for each cancer type to assess statistical significance. Hazard ratios with 95% CIs for any cause of overall survival were calculated using Cox proportional hazards regression models with the time since diagnosis.

Results: The survival rates for the six different types of cancer were as follows: stomach cancer, 69.6% (96,404/138,462); colorectal cancer, 66.6% (83,406/125,156); liver cancer, 33.7% (23,860/70,712); lung cancer, 30.4% (33,203/109,116); breast cancer, 91.5% (90,730/99,159); and cervical cancer, 78% (12,930/16,580). When comparing the medical aid group to the highest income group, the hazard ratios were 1.72 (95% CI 1.66‐1.79) for stomach cancer, 1.60 (95% CI 1.54‐1.56) for colorectal cancer, 1.51 (95% CI 1.45‐1.56) for liver cancer, 1.56 (95% CI 1.51‐1.59) for lung cancer, 2.19 (95% CI 2.01‐2.38) for breast cancer, and 1.65 (95% CI 1.46‐1.87) for cervical cancer. A higher deprivation index and advanced diagnostic stage were associated with an increased risk of mortality.

Conclusions: Socioeconomic status significantly mediates disparities in cancer survival in several cancer types. This effect is particularly pronounced in less fatal cancers such as breast cancer. Therefore, considering the type of cancer and socioeconomic factors, social and medical interventions such as early cancer detection and appropriate treatment are necessary for vulnerable populations.

JMIR Public Health Surveill 2024;10:e55011

doi:10.2196/55011

Keywords



Cancer is a major global cause of disease burden and one of the top three causes of death [1]. In South Korea, cancer is the leading cause of death [2], with 277,523 new cases of cancer reported in 2021 [3]. The most common cancer sites were the thyroid, lung, colon and rectum, stomach, and breast [3]. Among these, lung cancer has the highest mortality rate [2]. The South Korean government has established the National Cancer Screening Program (NCSP) to provide organized cancer screening to alleviate the burden of cancer [4], and the NCSP has contributed to a reduction in cancer mortality rates [5-8] The cancer incidence rate has increased by 56.5% from 2001 to 2021 [2]. Nevertheless, recent data from the past 5 years (2017‐2021) have shown a 17.9% increase in the 5-year survival rate for diagnosed patients with cancer compared with those diagnosed between 2001 and 2005 [9].

Cancer survival rates decrease with lower socioeconomic status (SES) factors such as income and educational levels [10-17]. Furthermore, the association between cancer incidence and mortality rates and SES varies according to cancer type [18-22]. Notably, for relatively preventable cancers such as cervical cancer, the mortality rate in the low-income group was twice that of the high-income group, whereas disparities in mortality rates for lung and liver cancers were comparatively narrower [11]. Furthermore, studies from Japan and the United States have found a correlation between measuring SES levels using the regional deprivation index and the risk of cancer mortality [23,24]. However, a similar relationship was not identified in a Korean study [25]. Therefore, more recent assessments are required to reduce socioeconomic disparities among patients with cancer.

In studies related to cancer survival rates, the stage of diagnosis is a significant factor explaining survival disparities [12,26-28]. However, despite extensive studies, the relationship between SES and disease stage at diagnosis and its effects on survival remains inconclusive. Studies in the United States have found an association between SES and disease stage at diagnosis [26,29], but a large-scale study conducted in the United Kingdom did not confirm these observations, despite noting survival disparities among social groups [30].

Analyzing socioeconomic patterns in the survival of patients with cancer is important because it allows the quantification of cancer-related health disparities between the most disadvantaged and most advantaged social groups [18]. These analyses help identify regions or population groups at the highest risk of death so that they can benefit from interventions such as early cancer screening and appropriate cancer treatment [18,20].

In many countries, large-population data have been utilized to analyze differences in cancer survival rates based on SES across various cancer types [11,18-20,31]. However, studies from this perspective have been limited to South Korea. Therefore, this study aims to analyze differences in survival rates among patients diagnosed with six types of cancer—stomach, colorectal, liver, breast, cervical, and lung cancers—based on SES using Korean nationwide data.


Data Source and Study Population

The Korean National Health Insurance Service (NHIS) is a government insurer that promotes the health of the population by providing a universal health insurance program that covers the entire population. The National Health Information Database (NHID) of the NHIS is a public database of anonymized participant information on sociodemographic variables, medical records, health care use, health screening, and mortality across the entire population. Further details regarding the database profile have been outlined elsewhere [32,33].

Our study data were obtained from the Korea Central Cancer Registry (KCCR) database, which was then linked to the national claims data from the NHID using unique personal identification numbers with the consent of the KCCR (NHIS-2022-1-114) [32,34]. The included populations in this analysis were patients who were primarily diagnosed with stomach cancer (C16), colorectal cancer (C18-20), liver cancer (C22), lung cancer (C33-34), breast cancer (C50), and cervical cancer (C53) based on International Statistical Classification of Diseases, Tenth Revision codes from 2014 to 2018 and were followed up with until December 31, 2021 [35].

In total, 11,209 patients with unknown income status, regional area that indicates the deprivation index quartile, and survival period were excluded for gastric cancer (n=140,873), colon cancer (n=127,525), liver cancer (n=72,303), lung cancer (n=111,284), breast cancer (n=101,752), and cervical cancer (n=17,032). This study analyzed the survival rates of the remaining patients with stomach cancer (n=138,462), colorectal cancer (n=125,156), liver cancer (n=70,712), lung cancer (n=109,116), breast cancer (n=99,553), and cervical cancer (n=16,580).

Ethical Considerations

This study was approved by the institutional review board of the National Cancer Center (NCC2021-0264). The review board waived the requirement for written informed consent from the patients because the data are public and anonymized under confidentiality guidelines.

Definition of Variables

Income level was classified into six categories. After being classified as National Medical Aid beneficiaries or National Health Insurance subscribers (for workplace health insurance subscribers and local subscribers), the latter group was subclassified into five segments, from the lowest (first, grades 1‐4) to highest (fifth, grades 17‐20), according to 20 insurance premium grades. The National Medical Aid program is a form of subsidized government assistance that provides coverage to low-income populations with health care services [36].

The Korean deprivation index, developed by the Korea Institute for Health and Social Affairs, is an indicator of the SES of a region by considering nine socioeconomic determinants: living alone, not owning a car, having an underdeveloped living environment, not living in an apartment, living in a female-headed household, having a low level of education, having an older population, having low social class, and being divorced or widowed [37]. Higher deprivation index values indicate more significant levels of deprivation, with values spanning from −20.33 to 15.15. Korea comprises 250 municipal-level units (otherwise known as sigungu), and deprivation and cancer survival rates were provided for all municipal-level areas [38]. The deprivation index was further divided into quartiles, with Q1 representing the most deprived and Q4 indicating the least deprived. In this categorization, the first quartile included 25% of the municipal-level units with the lowest deprivation scores, whereas the fourth quartile encompassed 25% of the municipal-level units with the highest deprivation scores.

Age at diagnosis was classified into three groups: ≤49, 50‐69, and ≥70 years. The stage at diagnosis was classified as localized, regional, distant, and unknown using the Surveillance, Epidemiology, and End Results (SEER) staging system.

Statistical Analyses

Kaplan-Meier curves stratified by income status were generated, and log-rank statistical significance tests were performed for each cancer type. Hazard ratios (HRs) with 95% CIs for any cause of overall survival were calculated using Cox proportional hazards regression models with time since diagnosis. The model was adjusted for sex, age at diagnosis, stage at diagnosis, and deprivation index. Income status was the primary predictor after adjusting for other statistically significant variables in the Kaplan-Meier survival log-rank tests.

SAS version 9.4 (SAS Institute) was used for all analyses, and the figures were generated using R software version 4.3.0 (The R Foundation for Statistical Computing). P values <.05 were considered statistically significant.


Table 1 provides an overview of the general characteristics of the patients with cancer. Across the income groups, the highest income group had the highest proportion of all six cancer types. The proportions were as follows: stomach cancer, 30.2% (41,792/138,462); colorectal cancer, 28.5% (35,663/125,156); liver cancer, 26.8% (18,976/70,712); lung cancer, 31.3% (34,159/109,116); breast cancer, 28.2% (27,929/199,159); and cervical cancer, 20.5% (3403/16,580). The medical aid group had the lowest proportions: 4.8% (6633/138,462) for stomach cancer, 5.7% (7160/125,156) for colorectal cancer, 7.1% (4989/70,712) for liver cancer, 7% (7650/109,116) for lung cancer, 3.3% (3305/99,159) for breast cancer, and 5.3% (887/16,580) for cervical cancer. The distribution of SEER stages was as follows: stomach cancer, 63.7% (88,263/138,462); liver cancer, 45.4% (32,136/70,712); breast cancer, 58.4% (57,891/99,159); and cervical cancer, 55.4% (9187/16,580), indicating the highest proportion of localized cases. However, for colorectal cancer, 42.4% (53,004/125,156) of cases were in the regional stage, whereas lung cancer had the highest proportion in the distant stage (47,789/109,116, 43.8%). The deprivation index revealed that for all six cancer types, the highest proportion was in Q4 (least deprived) and the lowest proportion was in Q1 (most deprived). The survival rates for stomach, colorectal, liver, lung, breast, and cervical cancers were 69.6% (96,404/138,462), 66.6% (83,406/125,156), 33.7% (23,860/70,712), 30.4% (33,203/109,116), 91.5% (90,730/99,159), and 78% (12,930/16,580), respectively. Breast cancer had the highest survival rate, whereas lung cancer had the lowest. The mean survival times for stomach, colorectal, liver, lung, breast, and cervical cancers were 5.84 (SD 3.01), 5.73 (SD 3.01), 3.35 (SD 3.30), 3.09 (SD 3.20), 7.17 (SD 1.60), and 6.38 (SD 2.55) years, respectively. The Kaplan-Meier analysis and log-rank test revealed significant differences in survival rates among the income level groups (Figure 1).

Table 1. General characteristics of patients with cancer.
VariableStomach
(n=138,462)
Colorectal
(n=125,156)
Liver (n=70,712)Lung
(n=109,116)
Breast
(n=99,159)
Cervical (n=16,580)
Patients, n%Patients, n%Patients, n%Patients, n%Patients, n%Patients, n%
Sex
Male93,24067.374,08659.252,84674.775,22568.900.000.0
Female45,22232.751,07040.817,86625.333,89131.199,159100.016,580100.0
Age at diagnosis (years)
≤4917,62012.714,37611.5867112.353584.943,81444.2768946.4
50‐6970,37350.860,16048.137,86953.646,89843.045,97946.4612036.9
≥7050,46936.450,62040.424,17234.256,86052.193669.5277116.7
Surveillance, Epidemiology, and End Results stage
Localized88,26363.744,35735.432,13645.424,27522.257,89458.4918755.4
Regional28,00120.253,00442.417,44024.728,53526.233,29733.6471728.4
Distant15,24611.020,78216.610,99215.547,78943.849115.015319.2
Unknown69525.070135.610,14414.385177.830603.111456.9
Income
Medical aid66334.871605.749897.176507.033053.38875.3
1 (lowest)20,69414.919,82515.810,97715.516,01014.716,91117.1324919.6
218,88313.617,39513.910,23914.513,56312.415,20315.3287217.3
321,56415.619,88315.911,44316.216,01414.715,83216.0303118.3
428,89620.925,23020.214,08819.921,72019.919,97920.2313818.9
5 (highest)41,79230.235,66328.518,97626.834,15931.327,92928.2340320.5
Deprivation index
Q1 (most deprived)14,94810.811,9859.6797511.313,10712.047984.811366.9
Q226,60619.223,76719.014,15020.021,64719.815,15515.3290417.5
Q348,84535.345,53736.425,17635.638,35535.236,46936.8622337.5
Q4 (least deprived)48,06334.743,86735.023,41133.136,00733.042,73743.1631738.1
Figure 1. Kaplan-Meier curves for (A) stomach, (B) colorectal, (C) liver, (D) lung, (E) breast, and (F) cervical cancers among different income groups.

After adjusting for sex, age at diagnosis, SEER stage, and deprivation index, the risk of death increased as the income level decreased across all six cancer types (Table 2). When comparing the medical aid group to the highest income group, the HRs were 1.72 (95% CI 1.66‐1.79) for stomach cancer, 1.60 (95% CI 1.54‐1.56) for colorectal cancer, 1.51 (95% CI 1.45‐1.56) for liver cancer, 1.56 (95% CI 1.51‐1.59) for lung cancer, 2.19 (95% CI 2.01‐2.38) for breast cancer, and 1.65 (95% CI 1.46‐1.87) for cervical cancer. A high deprivation index was associated with a higher risk of death, especially when comparing the least deprived group with the most deprived group. In these cases, the HRs for stomach, colorectal, liver, lung, breast, and cervical cancers were 1.13 (95% CI 1.10‐1.17), 1.13 (95% CI 1.09‐1.17), 1.08 (95% CI 1.05‐1.12), 1.19 (95% CI 1.16‐1.22), 1.19 (95% CI 1.09‐1.31), and 1.16 (95% CI 1.03‐1.31), respectively. Furthermore, as the disease progressed and the patients aged, a higher risk of death was observed.

Table 2. Adjusted hazard ratios (HRs) from Cox proportional hazards regression model among patients with cancer. Adjusted for sex; age at diagnosis; income; Surveillance, Epidemiology, and End Results stage; and deprivation index.
VariableStomachColorectalLiverLungBreastCervical
HR95% CIHR95% CIHR95% CIHR95% CIHR95% CIHR95% CI
Sex
Male1.00Reference1.00Reference1.00Reference1.00Referencea
Female0.930.91‐0.950.920.91‐0.940.940.92‐0.960.600.59‐0.61
Age at diagnosis (years)
≤491.00Reference1.00Reference1.00Reference1.00Reference1.00Reference1.00Reference
50‐691.151.11‐1.191.311.26‐1.371.041.01‐1.071.431.37‐1.491.301.23‐1.361.161.06‐1.26
≥703.143.03‐3.263.963.81‐4.132.001.93‐2.063.102.97‐3.234.324.07‐4.583.903.58‐4.24
Income
Medical aid1.721.66‐1.791.601.54‐1.661.511.45‐1.561.551.51‐1.592.182.01‐2.381.651.46‐1.87
1 (lowest)1.201.16–1.231.141.11‐1.181.291.26‐1.331.191.16‐1.221.311.22‐1.401.211.10‐1.35
21.181.15‐1.221.111.08‐1.151.241.20‐1.271.191.16‐1.221.271.18‐1.361.191.06‐1.32
31.131.09‐1.161.091.05‐1.121.221.19‐1.261.141.12‐1.171.181.10‐1.271.141.02‐1.27
41.041.01‐1.071.041.01‐1.071.081.05‐1.111.091.06‐1.111.181.10‐1.260.940.84‐1.05
5 (highest)1.00Reference1.00Reference1.00Reference1.00Reference1.00Reference1.00Reference
Surveillance, Epidemiology, and End Results stage
Localized1.00Reference1.00Reference1.00Reference1.00Reference1.00Reference1.00Reference
Regional4.554.44‐4.671.731.68‐1.782.852.78‐2.922.132.08‐2.193.062.89‐3.243.403.11–3.72
Distant25.4324.76‐26.1110.7510.45‐11.066.676.50‐6.856.045.90‐6.1926.5725.05‐28.1814.4713.17‐15.90
Unknown7.647.38‐7.924.634.45‐4.812.352.29‐2.423.523.41‐3.645.665.16‐6.214.433.93‐5.00
Deprivation index
1 (most deprived)1.131.10‐1.171.131.09‐1.171.081.05‐1.121.191.16‐1.221.191.09‐1.311.161.03‐1.31
21.061.04‐1.091.061.03‐1.091.041.01‐1.071.121.10‐1.151.101.03‐1.171.121.02‐1.23
31.020.99‐1.041.041.02‐1.071.031.01‐1.051.051.03‐1.061.020.98‐1.081.161.07‐1.25
4 (least deprived)1.00Reference1.00Reference1.00Reference1.00Reference1.00Reference1.00Reference

aNot applicable.


Principal Results

The survival rates for the six different types of cancer were as follows: stomach cancer, 69.6% (96,404/138,462); colorectal cancer, 66.6% (83,406/125,156); liver cancer, 33.7% (23,860/70,712); lung cancer, 30.4% (33,203/109,116); breast cancer, 91.5% (90,730/99,159); and cervical cancer, 78% (12,930/16,580). Our results show a trend similar to the 5-year survival rates in South Korea from 2017 to 2021 [9]. Compared with the 5-year survival rates from 2001 to 2005, stomach, liver, lung, breast, and cervical cancers had higher survival rates, whereas colorectal cancer had a lower survival rate [9]. However, notably, these differences may be influenced by methodological variations in survival rate calculation; thus, direct comparisons may have limitations.

Previous studies have confirmed that these survival rates are influenced by socioeconomic factors, such as income level [10-17]. In this study, we also observed a trend wherein lower income levels were associated with a higher risk of mortality for all six cancer types. This emphasizes the reduced survival prospects for low-income patients following a cancer diagnosis, with a more pronounced pattern compared with the highest-income and medical aid groups.

Interestingly, for breast cancer, which has a high survival rate, the effects of low income on the risk of death due to cancer were most pronounced. In contrast, for cancer types with lower survival rates, such as liver and lung cancers, income levels had a smaller influence. These results support those of previous studies indicating that income-related factors may have a greater effect on the survival of less fatal cancer types [11,39,40]. Similar trends were observed in studies conducted in the United States, where for preventable cancers such as cervical cancer, the mortality rate among low-income individuals was twice as high as that among high-income individuals. However, for high-mortality cancer types, such as liver and lung cancers, the differences were relatively small [11].

Furthermore, as the deprivation index increased, the risk of death also increased. This trend has also been observed in studies conducted in Japan and the United States [23,24]. However, this finding may differ from that of domestic studies. In a study focusing on the Gwangju-Jeonnam region in South Korea, no significant correlation was found between the deprivation index and cancer survival rates [25]. These divergent results may be owing to the fact that this study used a deprivation index at the municipal level for the entire country of South Korea, whereas Kang et al’s [25] study was limited to a specific region. Considering the limited number of previous studies analyzing the relationship between regional deprivation and survival rates, further studies are required to obtain clearer and more consistent results.

The diagnostic stage is recognized as a crucial factor in explaining survival disparities [12,26-28,41], as confirmed in this study. When cancer was diagnosed at an advanced stage, a higher risk of death was observed. Although numerous countries have conducted studies on this topic, the relationship between the disease stage at diagnosis and survival in the context of SES is still not fully understood. A study in the United States has suggested that lower SES leads to delayed diagnosis and less aggressive treatment, resulting in an increased risk of cancer-related death [29]. However, a large-scale study in Canada did not find a strong association between diagnostic stage and survival disparities across SES groups [42]. These variations may be attributed to differences in health care systems and health insurance policies that affect access to cancer screening and care [42].

Our study confirmed that cancer survival rates decrease in conjunction with low SES factors. In particular, income level was prominent, especially in less fatal cancers such as breast cancer. Furthermore, the risk of death increased when cancer was diagnosed at an advanced stage. This emphasizes the importance of early cancer detection, especially in socioeconomically vulnerable populations. In 1999, the South Korean government established the NCSP with the aim of offering organized cancer screening to alleviate the burden of cancer [4]. Since then, the target population and types of cancer included in the NCSP have expanded, and it has been shown that the NCSP is effective in reducing cancer mortality rates [5-8]. Korea has experienced a consistent increase in cancer screening rates since the initiation of mass screening programs [4]. However, socioeconomic disparities remain a major cause of inequality, affecting participation in cancer screening services in Korea [43]. Therefore, to increase cancer survival rates among socioeconomically vulnerable patients, interventions in basic health care and cancer screening programs should be expanded, considering the characteristics of each cancer type. This can help to increase early cancer detection rates and provide appropriate treatment at the right time.

Limitations

Our study has some limitations. First, the analysis was limited to all-cause mortality. This limitation raises the possibility that differences in survival rates related to income levels may be attributed to differences in mortality rates due to causes other than cancer, potentially leading to an overestimation of the differences in cancer survival rates. Therefore, comprehensive data including cause-specific mortality rates related to income are required. Second, there were difficulties collecting actual income data; therefore, insurance premiums were used as proxies for income. For workplace subscribers, premiums are levied based on their salaries, whereas for local subscribers, premiums are assessed based on various sources of income, leading to potential differences in income levels between the groups. However, no other measure was considered superior as a proxy for real income because health insurance premiums within the 20th decile had no major problem representing actual income levels [44]. Third, we were unable to adjust for all potential confounding factors that could influence survival (eg, psychosocial and medical factors). Therefore, caution should be exercised when interpreting the HRs evaluated using the Cox proportional hazards model.

Conclusions

In summary, lower income levels are associated with a higher risk of cancer mortality. This effect is particularly pronounced in less fatal cancers such as breast cancer. Additionally, the deprivation index and stage of diagnosis influence the risk of cancer mortality. Therefore, considering the characteristics of each cancer type and socioeconomic factors, it is essential to improve access to basic health care and interventions in cancer screening programs to increase early detection rates and provide appropriate treatment to socioeconomically vulnerable populations.

Acknowledgments

This study was supported by a grant-in-aid for cancer research and control from the National Cancer Center of Korea (grant 2110550-3, 2210773-3)

Data Availability

The data sets generated and analyzed during this study are not publicly available because the National Health Insurance Service (NHIS) exclusively allows authorized persons to access data in a separate space. Upon an individual researcher’s data set request, NHIS provides customized data to the researcher from the National Health Insurance Sharing Service [45].

Conflicts of Interest

None declared.

  1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. [CrossRef] [Medline]
  2. Ministry of Health and Welfare. Deaths and death rates by cause(104 item)/by sex/by age(five-year age). Korean Statistical Information Service. 2022. URL: https://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B34E01&conn_path=I2&language=en [Accessed 2024-05-21]
  3. Ministry of Health and Welfare. Cancer incident cases and incidence rates by site(24 items), sex, age group. Korean Statistical Information Service. 2021. URL: https://kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_117N_A00023&conn_path=I2&language=en [Accessed 2024-05-21]
  4. Suh M, Choi KS, Park B, et al. Trends in cancer screening rates among Korean men and women: results of the Korean National Cancer Screening Survey, 2004-2013. Cancer Res Treat. Jan 2016;48(1):1-10. [CrossRef] [Medline]
  5. Choi E, Jun JK, Suh M, et al. Effectiveness of the Korean National Cancer Screening Program in reducing breast cancer mortality. NPJ Breast Cancer. Jun 28, 2021;7(1):83. [CrossRef] [Medline]
  6. Kwon JW, Tchoe HJ, Lee J, Suh JK, Lee JH, Shin S. The impact of national surveillance for liver cancer: results from real-world setting in Korea. Gut Liver. Jan 15, 2020;14(1):108-116. [CrossRef] [Medline]
  7. Jun JK, Choi KS, Lee HY, et al. Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology. May 2017;152(6):1319-1328. [CrossRef] [Medline]
  8. Luu XQ, Lee K, Jun JK, Suh M, Jung KW, Choi KS. Effect of colorectal cancer screening on long-term survival of colorectal cancer patients: results of the Korea National Cancer Screening Program. Int J Cancer. Jun 15, 2022;150(12):1958-1967. [CrossRef] [Medline]
  9. Ministry of Health and Welfare. Relative survival rate for 5 years by 24 kinds of cancer, cancer occurrence time and gender. Korean Statistical Information Service. 2021. URL: https://kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_117N_A00021&conn_path=I2&language=en [Accessed 2024-05-22]
  10. Kennedy BP, Kawachi I, Prothrow-Stith D. Income distribution and mortality: cross sectional ecological study of the Robin Hood index in the United States. BMJ. Apr 20, 1996;312(7037):1004-1007. [CrossRef] [Medline]
  11. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. Jan 2019;69(1):7-34. [CrossRef] [Medline]
  12. Coughlin SS. Social determinants of breast cancer risk, stage, and survival. Breast Cancer Res Treat. Oct 2019;177(3):537-548. [CrossRef] [Medline]
  13. Carethers JM, Doubeni CA. Causes of socioeconomic disparities in colorectal cancer and intervention framework and strategies. Gastroenterology. Jan 2020;158(2):354-367. [CrossRef] [Medline]
  14. Fairfield KM, Black AW, Ziller EC, et al. Area deprivation index and rurality in relation to lung cancer prevalence and mortality in a rural state. JNCI Cancer Spectr. Mar 7, 2020;4(4):kaa011. [CrossRef] [Medline]
  15. Sengayi-Muchengeti M, Joko-Fru WY, Miranda-Filho A, et al. Cervical cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index: a population-based registry study. Int J Cancer. Dec 1, 2020;147(11):3037-3048. [CrossRef] [Medline]
  16. Cheng E, Soulos PR, Irwin ML, et al. Neighborhood and individual socioeconomic disadvantage and survival among patients with nonmetastatic common cancers. JAMA Netw Open. Dec 1, 2021;4(12):e2139593. [CrossRef] [Medline]
  17. Flores YN, Datta GD, Yang L, et al. Disparities in hepatocellular carcinoma incidence, stage, and survival: a large population-based study. Cancer Epidemiol Biomarkers Prev. Jun 2021;30(6):1193-1199. [CrossRef] [Medline]
  18. Singh GK, Jemal A. Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950-2014: over six decades of changing patterns and widening inequalities. J Environ Public Health. 2017;2017:2819372. [CrossRef] [Medline]
  19. Dalton SO, Olsen MH, Johansen C, Olsen JH, Andersen KK. Socioeconomic inequality in cancer survival – changes over time. A population-based study, Denmark, 1987–2013. Acta Oncologica. May 4, 2019;58(5):737-744. [CrossRef]
  20. Tron L, Belot A, Fauvernier M, et al. Socioeconomic environment and disparities in cancer survival for 19 solid tumor sites: an analysis of the French Network of Cancer Registries (FRANCIM) data. Int J Cancer. Mar 15, 2019;144(6):1262-1274. [CrossRef] [Medline]
  21. Islami F, Guerra CE, Minihan A, et al. American Cancer Society's report on the status of cancer disparities in the United States, 2021. CA Cancer J Clin. Mar 2022;72(2):112-143. [CrossRef] [Medline]
  22. Zhao J, Han X, Nogueira L, et al. Health insurance status and cancer stage at diagnosis and survival in the United States. CA Cancer J Clin. Nov 2022;72(6):542-560. [CrossRef] [Medline]
  23. Odani S, Tabuchi T, Nakaya T, et al. Socioeconomic disparities in cancer survival: relation to stage at diagnosis, treatment, and centralization of patients to accredited hospitals, 2005-2014, Japan. Cancer Med. Mar 2023;12(5):6077-6091. [CrossRef] [Medline]
  24. Snider NG, Hastert TA, Nair M, et al. Area-level socioeconomic disadvantage and cancer survival in metropolitan Detroit. Cancer Epidemiol Biomarkers Prev. Mar 6, 2023;32(3):387-397. [CrossRef] [Medline]
  25. Kang JH, Kim CW, Kweon SS. The relationship between 5-year overall survival rate, socioeconomic status and SEER stage for four target cancers of the National Cancer Screening program in Korea: results from the Gwangju-Jeonnam Cancer Registry [Article in Korean]. J Korean Acad Community Health Nurs. Jun 30, 2022;33(2):237. [CrossRef]
  26. Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol. Jan 2006;17(1):5-19. [CrossRef] [Medline]
  27. Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. Jan 13, 2015;313(2):165-173. [CrossRef] [Medline]
  28. Finke I, Behrens G, Schwettmann L, et al. Socioeconomic differences and lung cancer survival in Germany: investigation based on population-based clinical cancer registration. Lung Cancer. Apr 2020;142:1-8. [CrossRef] [Medline]
  29. Byers TE, Wolf HJ, Bauer KR, et al. The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer. Aug 1, 2008;113(3):582-591. [CrossRef] [Medline]
  30. Brewster DH, Thomson CS, Hole DJ, Black RJ, Stroner PL, Gillis CR. Relation between socioeconomic status and tumour stage in patients with breast, colorectal, ovarian, and lung cancer: results from four national, population based studies. BMJ. Apr 7, 2001;322(7290):830-831. [CrossRef] [Medline]
  31. McPhail S, Johnson S, Greenberg D, Peake M, Rous B. Stage at diagnosis and early mortality from cancer in England. Br J Cancer. Mar 31, 2015;112(Suppl 1):S108-S115. [CrossRef] [Medline]
  32. Cheol Seong S, Kim YY, Khang YH, et al. Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. Jun 1, 2017;46(3):799-800. [CrossRef] [Medline]
  33. Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. Apr 1, 2017;46(2):e15. [CrossRef] [Medline]
  34. Shin HR, Won YJ, Jung KW, et al. Nationwide cancer incidence in Korea, 1999~2001; first result using the National Cancer Incidence Database. Cancer Res Treat. Dec 2005;37(6):325-331. [CrossRef] [Medline]
  35. ICD-10: International Statistical Classification of Diseases and Related Health Problems: Tenth Revision, 2nd ed. World Health Organization. 2010. URL: https://iris.who.int/handle/10665/42980 [Accessed 2024-07-09]
  36. Park S. Medical service utilization and out-of-pocket spending among near-poor National Health Insurance members in South Korea. BMC Health Serv Res. Aug 28, 2021;21(1):886. [CrossRef] [Medline]
  37. Kim D, Lee S, Ki M, et al. Developing Health Inequalities Indicators and Monitoring the Status of Health Inequalities in Korea. Korea Institute for Health and Social Affairs; 2013:166-179. URL: https://www.kihasa.re.kr/publish/report/view?type=all&seq=27544 [Accessed 2024-07-09]
  38. Nari F, Park J, Kim N, et al. Impact of health disparities on national breast cancer screening participation rates in South Korea. Sci Rep. Aug 14, 2023;13(1):13172. [CrossRef] [Medline]
  39. Yim J, Hwang SS, Yoo KY, Kim CY. Contribution of income-related inequality and healthcare utilisation to survival in cancers of the lung, liver, stomach and colon. J Epidemiol Community Health. Jan 2012;66(1):37-40. [CrossRef] [Medline]
  40. Bradley CJ, Given CW, Roberts C. Disparities in cancer diagnosis and survival. Cancer. Jan 1, 2001;91(1):178-188. [CrossRef] [Medline]
  41. Auvinen A, Karjalainen S. Possible explanations for social class differences in cancer patient survival. IARC Sci Publ. 1997;(138):377-397. [Medline]
  42. Booth CM, Li G, Zhang-Salomons J, Mackillop WJ. The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada. Cancer. Sep 1, 2010;116(17):4160-4167. [CrossRef] [Medline]
  43. Kim S, Hwang J. Assessment of trends in socioeconomic inequalities in cancer screening services in Korea, 1998-2012. Int J Equity Health. Feb 24, 2016;15:30. [CrossRef] [Medline]
  44. Seo NK, Ahn SZ. A study on the adequacy of national health insurance premium quantiles as the basis for determining income level. Korea Soc Policy Rev. 2021;28(1):265-288. [CrossRef]
  45. National Health Insurance Service. URL: https://nhiss.nhis.or.kr/bd/ay/bdaya003iv.do [Accessed 2024-07-08]


HR: hazard ratio
KCCR: Korea Central Cancer Registry
NCSP: National Cancer Screening Program
NHID: National Health Information Database
NHIS: National Health Insurance Service
SEER: Surveillance, Epidemiology, and End Results
SES: socioeconomic status


Edited by Amaryllis Mavragani; submitted 30.11.23; peer-reviewed by Sina Azadnajafabad, Tran Thang; final revised version received 23.05.24; accepted 24.05.24; published 22.07.24.

Copyright

© JinWook Lee, JuWon Park, Nayeon Kim, Fatima Nari, Seowoo Bae, Hyeon Ji Lee, Mingyu Lee, Jae Kwan Jun, Kui Son Choi, Mina Suh. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 22.7.2024.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on https://publichealth.jmir.org, as well as this copyright and license information must be included.